Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celgene gives up on lucrative new use for linchpin drug Revlimid, clouding hopes for $1B-plus revenue boost
Celgene gives up on lucrative new use for linchpin drug Revlimid, clouding hopes for $1B-plus revenue boost
Celgene gives up on lucrative new use for linchpin drug Revlimid, clouding hopes for $1B-plus revenue boost
Submitted by
admin
on July 26, 2016 - 9:46pm
Source:
Fierce Pharma
News Tags:
Celgene
Revlimid
diffuse large B-cell lymphoma
Headline:
Celgene gives up on lucrative new use for linchpin drug Revlimid, clouding hopes for $1B-plus revenue boost
Do Not Allow Advertisers to Use My Personal information
